Element Wealth LLC Cuts Stake in Aflac Incorporated (NYSE:AFL)

Element Wealth LLC reduced its stake in Aflac Incorporated (NYSE:AFL) by 10.3% during the fourth quarter, HoldingsChannel reports. The fund owned 3,200 shares of the financial services provider’s stock after selling 367 shares during the period. Element Wealth LLC’s holdings in Aflac were worth $264,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Flputnam Investment Management Co. lifted its holdings in shares of Aflac by 0.5% during the fourth quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock valued at $2,065,000 after purchasing an additional 122 shares in the last quarter. Baystate Wealth Management LLC lifted its holdings in shares of Aflac by 24.1% during the third quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 131 shares in the last quarter. Dominguez Wealth Management Solutions Inc. lifted its holdings in shares of Aflac by 0.5% during the third quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock valued at $1,916,000 after purchasing an additional 132 shares in the last quarter. Brighton Jones LLC lifted its holdings in shares of Aflac by 2.3% during the third quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock valued at $472,000 after purchasing an additional 136 shares in the last quarter. Finally, MV Capital Management Inc. lifted its holdings in shares of Aflac by 3.7% during the third quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock valued at $290,000 after purchasing an additional 136 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AFL has been the topic of a number of research analyst reports. StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a report on Wednesday, April 10th. Raymond James raised their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Wells Fargo & Company decreased their price objective on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 11th. Piper Sandler increased their target price on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. Finally, Morgan Stanley raised their price target on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $82.15.

Insider Activity at Aflac

In other Aflac news, Director Masatoshi Koide sold 30,493 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the sale, the director now owns 86,090 shares in the company, valued at approximately $6,879,451.90. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the sale, the senior vice president now directly owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the sale, the director now directly owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The disclosure for this sale can be found here. In the last three months, insiders have sold 46,493 shares of company stock valued at $3,765,706. 0.80% of the stock is owned by corporate insiders.

Aflac Stock Up 0.3 %

Shares of NYSE AFL traded up $0.23 during trading hours on Tuesday, hitting $83.75. 1,760,566 shares of the stock were exchanged, compared to its average volume of 2,282,082. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a 12 month low of $64.10 and a 12 month high of $86.26. The company has a market cap of $48.19 billion, a PE ratio of 10.78, a PEG ratio of 2.28 and a beta of 0.91. The firm has a fifty day moving average price of $82.31 and a 200-day moving average price of $81.64.

Aflac (NYSE:AFL) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). The business had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same period last year, the business earned $1.29 EPS. On average, sell-side analysts expect that Aflac Incorporated will post 6.41 EPS for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.